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Quality of Life in Epilepsy: Multidimensional Profile
and Underlying Latent Dimensions
1Theo P. B. M. Suurmeijer, 2Marieke F. Reuvekamp, 3Bert P. Aldenkamp,
2Jan Overweg, and 4On Gie Sie
Part of our study, the Dutch Quality of Life and Quality of Care Investigation
in Epilepsy (DUQQIE), intended to cover several of the components of the
quality of life (QoL) concept. To this end, a series of already existing generic
and disease-specific instruments was selected covering several parts of the
QoL components in order to construct a multidimensional ‘‘QoL profile’’ for
people with epilepsy and to look for underlying second-order QoL dimen-
sions. From the records of four outpatient clinics, 210 persons with epilepsy
were randomly selected. During their visit to the outpatient clinic, they
completed a questionnaire assessing, among others, health perceptions, psy-
chological well-being, and social functioning. Additional information about
their medical and psycho–social status was gathered from the patient files. A
large part of our research group was not seizure-free. As far as comparisons
with other patient or healthy groups could be made, it appeared that they
mostly did not (much) worse and all scores were above the scale midpoint.
However, almost two-thirds of the scale means lied below a so-called ‘‘nor-
mative mean.’’ Higher-order factor analysis yielded one general factor mea-
suring the ‘‘Overall Quality of Life.’’ Furthermore, after rotation of this general
factor, two separate factors could be constructed referring to the psycho–
physical and psycho–social aspects of QoL, respectively. We decided not to
develop ‘‘quality of life instrument’’ de novo to the already vast and ever
increasing area of QoL instruments, but to use already existing, mostly generic,
and well-validated instruments. The most important advantage of this ap-
proach is that it allows for ‘‘normative controls’’ (norms; other groups) and
‘‘conceptual modeling.’’ The latter is that the QoL concept can be unfolded into
its component parts and hypothetically related to each other. Key Words:
Quality of life—Profile—Epilepsy—Adults. © 1998 by Elsevier Science Inc.
All rights reserved.
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Quality of life (QoL) is a widely used concept
often referred to as ‘‘health related quality of life’’
(HRQL) as far as QoL is related to the conse-
quences of disease and medical interventions (1–
3). Although the concept is widely known, it may,
however, mean different things to different peo-
ple (3– 6). The ideas about the concept of QoL
have strongly been influenced by the WHO def-
inition of health (7), and generally one agrees
about the idea that clinical data only do not
suffice to carefully evaluate and understand the
consequences of chronic illness and medical in-
terventions for the QoL of the persons involved.
In case of a chronic condition, the life-style of
affected individuals may be strongly disrupted,
‘‘…interfering with continued involvements in
valued activities and interests, and compromis-
ing quality of life’’ (8). Adjustment to a chronic
illness, such as epilepsy, is not merely a function
of the severity or duration of the disorder. Re-
sponses from the family and other significant
others may be more menacing than the illness
itself (9 –12). Since the consequences are much
far-reaching than only the physical aspect (i.e.,
seizures), a broad approach of the conceptualiza-
tion and assessment of QoL in epilepsy is often
strongly being advocated and should contain not
only the assessment and evaluation of seizures,
but also other life domains such as cognitive and
emotional functioning, role activities and social
functioning, health perceptions, and general sat-
isfaction with life (3,6,13). A chronic illness may
not only mean a gradual deterioration of the body
but, as a consequence, also of one’s self-concept
and social relationships (14 –16).
In a medical–sociological model, the patient’s
experience of illness is emphasized and it is con-
cerned with how understandings of illness may
vary (17). As Devinsky and Cramer (18) stated:
‘‘The patient is the only one who knows how he
or she feels, how the disorder affects that person’s
vigour, self-confidence, ability to socialize, obtain
work, and function at home and on the job.
Surely, the patient’s reports may be biased, as
may be the doctor’s. However, the patient is the
person who must define his own quality of life
…Only the patient knows if an imbalance exists
between expectations and reality…’’ (19). This
corresponds to the WHOQOL-group definition of
quality of life: ‘‘individuals’ perception of their
position in life in the context of the culture and
the value system in which they live and in rela-
tion to their goals, expectations, standards, and
concerns’’ (19). On the basis of these consider-
ations, we took the patient’s perspective on QoL
as our starting point in our study ‘‘The Dutch
Quality of Care and Quality of Life Inventory for
Epilepsy’’ (DUQQIE).
Quality of Life: Levels and Measurement
Spilker (20) claims that QoL must be viewed on three
levels (Fig. 1). Level one contains the overall assessment
of QoL and is defined as ‘‘an individual’s overall satis-
faction with life, and one’s general sense of personal
well-being’’ (21). This is also often referred to as ‘‘clinical
global impression,’’ a question that can ‘‘…be best an-
swered by the patient and not by the physician’’ (20).
The second level comprises the major domains of QoL
the physical, mental, and social domain (including so-
cial–economic aspects such as occupational role and
academic achievements) (20,22). The third level includes
specific aspects of each domain. The model assumes that
lower level variables or aspects determine the more
general valuations on a higher level and ultimately the
‘‘overall assessment of well-being.’’
Another important issue is the question of which type
of measure should be used: a disease-specific measure or
a generic measure (1,23,24). If one’s aim is to assess
similarities and dissimilarities of psychosocial conse-
quences across chronic illnesses, generic measures
should be chosen [‘‘noncategorical approach’’ to chronic
disorders (25–32)]. Moreover, only these latter measures
allow for studying the cause-and-effect patterns be-
tween QoL dimensions or aspects across disorders. If
one wishes to collect additional information on specific
aspects of a particular disorder, supplementary ‘‘dis-
ease-specific’’ measures may be added (28).
The short-term aim of this article (i.e., the research
questions to be addressed) is to find out what the QoL
of our adult respondents looks like. More specific:
first, to give a description of the QoL profile of the
respondents of our research group and the proce-
dures used to construct such a profile; second, to
compare our findings to those of other studies (spe-
cific groups and ‘‘normative data’’); and third, to
explore the feasibility and usefulness to construct
more overall QoL measures based on dimension-
specific measures. The long-term aim of our study
would be to get an insight in and explanation of
(dis)similarities in QoL aspects across diseases and
healthy populations. Such a long-term aim can only
be achieved by carefully comparing outcomes of stud-
ies, using similar generic measures among samples
consisting of people with various chronic disorders.
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Materials and Methods
Sample
Patients were selected from outpatient clinics of
the Department of Neurology of the University
Hospital in Groningen and of the special epilepsy
centre ‘‘Meer en Bosch’’ in Heemstede, in total four
outpatients clinics, all in the northern region of The
Netherlands. Patients who came for an appoint-
ment with their neurologist, were eligible for en-
rollment into the study. To be included in/ex-
cluded from our study the following criteria were
used: (1) inclusion criteria: ages from 18–65 years,
and a definite diagnosis of epilepsy; (2) exclusion
criteria: malign epilepsy syndromes accompanied
by a mental handicap or the presence of sever
psychiatric disturbances as reflected in an earlier
psychiatric admission. Of the 275 patients with
epilepsy who all fulfilled these inclusion and exclu-
sion criteria for enrollment in the study, 225 (82%)
participated. Because of missing data or unclear
answers, 210 persons were used in the final anal-
yses.
The patients were asked to fill out a question-
naire at the same day they visited their neurologist
at the outpatient department. During this session
they were supervised by the research assistant. In
addition, the research assistant collected demo-
graphic and clinical data by means of both a short
interview with the patients and information from
their medical files. A letter of informed consent,
signed by the patients, was obtained from all the
subjects participation in the study.
Composition of the Research Group
Nonclinical Data
Of the 210 respondents, 51% were men and 49%
women. The mean age was 38 years (sd 5 11.4).
Sixty-six percent was married, a high percentage as
compared to the result of some other recent studies
(33,34). Approximately 30% was a member of the
Epilepsie Vereniging Nederland (EVN) which is the
Dutch patient organization for patients with epi-
lepsy, their parents, or partners. This percentage is
about 10 times as high as the corresponding per-
centage for the total group of people with epilepsy.
As compared to the Dutch population (35), the
educational level* of our group was generally be-
low average: 81% had only lower types of educa-
tion as opposed to 19% with a higher level of
education. Consequently, the employment status
was rather low: only 35% had paid jobs (Table 1).
Clinical Data
An overview of the clinical data is presented in
Table 2. Seventy-eight percent of our respondents
had an onset of epilepsy before the age of 21 years.
Furthermore, 12% had a generalized type of epi-
lepsy: 10% idiopathic and 2% symptomatic. As
much as 81% of our respondents had partial epi-
lepsy. Consequently, complex partial seizures were
most frequently encountered (Fig. 1).
The rather high percentage of partial epilepsy
may be a consequence of the composition of the
population from which we drew our sample (36),
the enrollment procedures used in our research,
and/or from the increasing possibilities of the
electroencephalogram (EEG) techniques and
other neuroimaging technique that more often
than before allow for the assessment of an epi-
*From 36 persons also the IQ was available. From this
it appeared that their IQ was average (mean IQ 5 101.6;
sd 5 14.1). This might perhaps indicate that our respon-
dents do dispose of adequate intellectual capacities and
that the achieved level of education would be more in
agreement with their capacities if they were not hindered
to do so because of an early onset of their epilepsy.
Table 1. Educational level and employment status
(in percentages)
Education Level Employment Status
Primary education 3 Full-time job 21
Lower vocational 56 Part-time job 14
Lower secondary 22 Sheltered workshop 12
Middle secondary/vocational 18 Disablement pension 24
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leptic focus (37,38). We will shortly return to this
issue in the Discussion section. Twenty patients
were seizure-free for at least 1 year. However,
most respondents (59%) still had regular seizures.
In 6%, a status epilepticus occurred. Seventy-one
percent used two or more antiepileptic drugs
(AEDs), with carbamazapine and sodium val-
proat most frequently used.
Measures and Analyses
Referring to our former discussion and the three-
level model of Spilker, we decided not to develop
QoL/HRQL measures de novo, but to look for a
number of overall, domain-specific, and dimen-
sion-specific generic instruments that (1) according
to Spilker’s conceptual model, discussed earlier,
cover both the general health perceptions and ad-
justment, and different aspects of physical, mental,
and social functioning; (2) that enable comparisons
to be made with some previous studies on QoL and
epilepsy; (3) that enable comparisons to be made
with other studies on QoL, both among samples of
people with other chronic conditions and among
healthy populations (‘‘normative data’’); (4) that for
the greater part have proven their reliability and
validity; and, (5) measures/instruments of which,
besides a Dutch version, also other language mod-
ules (e.g., an English and German version) are
available for reasons of comparisons with previous
studies as well as because of intended, planned
international research.
In our study we used 13 QoL measures. Five of
them were not generic (i.e., in the items of these
measures the word ‘‘epilepsy’’ was used). How-
ever, the word ‘‘epilepsy’’ can simply be replaced
by another chronic condition. Indeed, several of
these measures have been developed in studies
among samples with another chronic illness such as
rheumatoid arthritis (RA) and multiple sclerosis
(MS) (see below). Although these measures are
Table 2. Clinical data
Mean age of onset 15 years (sd 5 11.0)
Percentage onset before 21 years 78%
Mean duration 23 years (sd 5 12.3)
Unknown etiology 87%
Generalized type of epilepsy 12%
Partial epilepsy 81%
Unclassifiable type of epilepsy 7%
Figure 1. Frequency of seizure types.
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disease-related they are not disease-specific (i.e., only
applicable to a specific disease).
In Figure 2, the three QoL levels are presented in
combination with the accompanying measures we
used in our research. Table 3 gives further informa-
tion about these instruments: full name of measure,
format, range of scores, and interpretation of scores.
To assess the individual’s general health percep-
tions, we used three measures. Six items were se-
lected form the MOS-SF20 (39); these six items
appeared to constitute a hierarchical scale measur-
ing one’s health perceptions (HP) (40). In addition,
a visual analogue scale with ‘‘delighted-terrible fac-
es’’ (VAS-DT) was used in order to assess the pa-
tient’s valuation of his QoL (41,42). Also, one item
was added to assess one’s appraisal of the ‘‘general
adjustment to epilepsy’’ (GATE): ‘‘Do you think
that you have adjusted well to the situation and can
cope well with problems that have developed as a
consequence of epilepsy?’’ As part of a larger set of
items measuring the ‘‘subjective definition of an
illness,’’ a similar item was used in two other re-
search projects of which the first author is project
leader (one among RA patients and one among MS
patients).† Another item from this latter set of items
was also used in our study in order to measure the
‘‘appraisal of the severity of epilepsy’’ (ASE): ‘‘Ep-
ilepsy is a sever disease.’’ Notice that the term
‘‘epilepsy’’ in these items can easily be replaced by
any other label. This item was intended to measure
the ‘‘physical domain’’ of QoL together with five
items measuring ‘‘perception epilepsy seizures’’
(PES). These items came mainly from the QOLIE-89
(18,42). The ‘‘mental domain’’ was assessed by means
of well-validated instruments: the 28-item version
of the ‘‘General Health Questionnaire’’ (GHQ28)
(45–47) measuring psychological distress, the
‘‘Rosenberg Self-Esteem’’ scale (RSE) (48), and the
Mastery scale (MAS) (49). In addition, five items
from the MOS-SF20 (39) assessing ‘‘mental health’’
(MH), were used; these items appeared to consti-
tute a hierarchical scale (40). Finally, the ‘‘social
domain.’’ This was measured by the loneliness scale
(LS) (50,51). This is an 11-item Rasch scale assessing
the subjective experience of an unpleasant or inad-
missible lack of (quality of) certain social relations.
A phenomenon often mentioned in relationship to
epilepsy is stigma that is assumed to affect the
† Part of the results of the multiple sclerosis project
were published in 1997 (43). A description of the project
on rheumatism was presented in 1990 (44). Based on the
data of this latter project, many articles and two Ph.D.
theses have been published (e.g., see references 47, 64–
66). Several other Ph.D. theses are being prepared. Fur-
ther information both about these projects and publica-
tions can be obtained from the first author.
Figure 2. Levels of quality of life and accompanying measures.
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Table 3. Overview of quality of life measures by level and dimension
Scale Format Range of Scores Interpretation
Health perception Health perception (HP) Health perception, six statements:
absolutely true to absolutely
not true
6–31 Higher score indicates better
perceived health
Visual Analogue Scale Delighted-
Terrible Faces (VAS-DT)
Rating of QoL, one statement
using ‘‘delighted-terrible’’ faces
0–10 Higher score indicates better
perceived QoL
General Adjustment To Epilepsy
(GATE)
One statement: not at all to very
good
1–5 Higher score indicates better
adjustment
Illness perceptions Appraisal Severity Epilepsy
(ASE)
One statement: strongly agree to
strongly disagree
1–5 Higher score indicates perceiving




Five statements: very worried to
not at all worried and definite
to not at all
5–22 Higher score indicates less worry
Mental functioning Mental Health (MH) Mental health, five statements:
always to never




Four subscales with each seven
statements: not at all to much
more than usual
Per subscale 0–21; total
scale score: 0–84
Higher score indicates less
psychological well-being (or
more distress)
Mastery (MAS) Seven statements: strongly agree
to strongly disagree
7–28 Higher score indicates higher level
of mastery
Rosenberg Self-Esteem (RSE) 10 statements: strongly agree to
strongly disagree
10–40 Higher score indicates higher level
of self-esteem
Social funtioning Loneliness Scale (LS) 11 statements: strongly agree to
strongly disagree,
dichotomized: lonely and not
lonely
0–11 Higher score indicates less feelings
of loneliness
Perceived Stigma Epilepsy (PSE) Six statements: strongly agree to
strongly disagree




20 statements: very important to
not at all important, 20
statements: yes/no
260–60 Higher score indicates more life
fulfillment
Independent Living in Epilepsy
(ILE)
Two statements: strongly agree to
strongly disagree




























social position and social relations of people being
stigmatized. We measured stigma using the ‘‘per-
ception stigma epilepsy’’ (PSE) scale (52). The PSE
comprises items referring to both ‘‘enacted’’ and
‘‘felt’’ stigma (53). Life fulfillment was assessed by
the ‘‘life fulfillment questionnaire’’ (LFQ), an in-
strument developed by Collings (33,54–56). This
questionnaire consists of two sets of 20 items cov-
ering the following aspects of daily life: family life,
friends, social support, leisure activities, living ar-
rangements, material security, and employment. To
yield an LFQ score, a method was used similar to
the method developed by Krupinski (57). Respon-
dents first rated the importance they attached to
these various aspects of life irrespective of their
own circumstances (first set of 20 items), and then
indicated whether or not each aspect was true of
their own actual life situation (second set of 20
items). Next, the first and second ratings were mul-
tiplied by each other to yield fulfillment scores.
These fulfillment scores refer to a mental incongru-
ency (i.e., a discrepancy between desire and reality
and it is assumed that such a discrepancy causes
less social well-being—and probably less psycho-
logical well-being too). Finally, two items were
added measuring feelings of independence in rela-
tions with other people and it was called ‘‘Indepen-
dent Living in Epilepsy’’ (ILE). These items also
came from the RA research and MS research men-
tioned earlier. An item example is: ‘‘People with
epilepsy are able to do things equally well as com-
pared to other people.’’ These latter items resemble
the mastery items but they are specifically focused
on the appraisal of epilepsy in terms of indepen-
dence and have been formulated in terms of be-
havior.
As far as appropriate, we first calculated reliabil-
ity figures for all measures (factors or scales) by
using Cronbach’s alpha (a) (58).
Next, we constructed a QoL profile based on all
these measures (item, factor, or subscale). To this
end we used a procedure similar to the one fol-
lowed with the Sickness Impact Profile (SIP) (22).
First, the scores of each measure were recoded in
such a way that for all measures the lowest score
was zero. Next, per measure, a mean sum score was
calculated and divided by the maximum possible
score; this ratio was multiplied by 100. In fact, this
score is the percentage of the maximum score. In
this way we got standardized scores for each mea-
sure running from 0 to 100 with the lower scores
referring to worse QoL and the higher scores to
better QoL.
Finally, in order to construct a more overall QoL
measure, an explorative higher-order principal
component analysis (PCA) with orthogonal and
oblique rotations according to the varimax and
oblimin criterium was carried out. All the analyses
were conducted with SPSS/PC 1 V5.0.2 (59).
Results
Quality of Life Profile
First of all, reliability coefficients [Cronbach’s al-
pha (a)] have been calculated as far as appropriate.
In Table 4 these alphas are presented together with
the range, mean, and standard deviation of these
measures. Most Cronbach’s alphas appeared to be
acceptable (Ä.60), satisfactory (Ä.70), or good
(Ä.80).‡
Next, for each scale or measure, we calculated the
mean score and transformed them all, according to
the procedure described earlier, into scores that ran
from 0–100. Then, a QoL-profile for the group as a
whole could be made (Fig. 3).
From this profile it appears that the QoL of our
‡ Helmstadter (60) considers a reliability coefficient $
0.50 sufficient to evaluate group accomplishments. Nu-
nally (61) and Nunnally and Bernstein (62) recommend a
coefficient of 0.70 or above. These values are often en-
countered in the literature. Based on our own experience,
we chose a threshold value of $ 0.60.
Table 4. Range, scale mean, standard deviation,






HP 6–31 23.97 5.12 0.80
VAS-DT 0–10 7.57 1.80 OI
GATE 1–5 4.26 0.87 OI
ASE 1–5 2.94 1.40 OI
PES 5–22 16.08 3.53 0.71
MH 5–30 22.01 4.14 0.78
GHQdep 0–21 2.10 3.61 0.88
GHQa&i 0–21 5.25 4.49 0.86
GHQsd 0–21 7.08 2.73 0.83
GHQsom 0–21 5.70 4.16 0.81
GHQ28 0–84 20.14 12.19 0.93
RSE 10–40 30.12 4.67 0.86
MAS 7–28 20.33 3.27 0.75
LS 0–11 6.82 2.98 0.82
PSE 6–24 12.93 3.24 0.62
LFQ 260–160 19.24 15.02 0.68
ILE 2–10 7.23 2.27 0.62
OI, one item.
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respondents always lay above the scale midpoint
(i.e., above 50% of the maximum score that could be
reached on a particular measure). However, this
does not mean that their QoL is good or as good as
that of healthy persons, or that it is similar to that of
people with another chronic disease. At the mo-
ment, it would go too far to go into detail in this
respect, but, for example, compared to the Dutch
adult population, our respondents felt more lonely
and could, according to a series of reference values
presented by Ko¨nig-Zahn et al. (63), be classified as
‘‘moderate lonely.’’ Furthermore, they experienced
only slightly less distress than a cross-sectional
sample of people with MS (43) and about the same
degree as a sample of people with RA with a recent
onset (0–4 years). In this latter study, mean scores
expressed as the percentage of the maximum score
were: 76, 75, and 73, respectively (64–66). However,
this latter (RA) group scored significantly worse as
compared to a group of healthy controls (mean
score: 80). Self-esteem appeared to be about the
same for the three groups of patients (mean scores:
67, 65, and 64, respectively). However, 57% re-
ported a very satisfactory QoL that is comparable to
52% satisfied people found in the total adult Dutch
population (35). As compared to other groups of
people with epilepsy our sample felt quite well. For
example, only 4.5% of our respondents considered
their QoL as unsatisfactory (i.e., chose a ‘‘terrible
face’’) as contrasted to 15% found in a large re-
search in the United States (67). Baker and Jacoby
(68) reported 63% of their epilepsy research group
who chose a ‘‘happy face’’ to rate their satisfaction
with life. In our study this figure was 90%.
In order to find ‘‘…some agreed statistic which
could form the basis for comparison…,’’ Cummins
(69) compared QoL research outcomes of more than
1000 books and articles that (1) were scanned for
Figure 3. Profile QoL Epilepsy.
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normative data on QoL and (2) met a set of definite
methodological, statistic, and sampling criteria.
This resulted in 17 normative data sets (with a
diversity of QoL-scales) that fulfilled all of the nor-
mative criteria. Based on this study he hypothe-
sized a range of 75 6 2.5%, a value that he proposed
as a sort of ‘‘gold standard’’ in order to evaluate the
level of QoL of specific groups.
Looking at the mean scores of the various QoL
aspects measured in our research, it appears that 10
out of 17 scores were below this gold standard; four
of them (ASE, PES, PSE, and ILE) explicitly referred
to epilepsy itself (cf. Measures and Analyses sec-
tion). Furthermore, on five aspects, the scores were
within the hypothesized range while two exceeded
the proposed upper limit. However, from the over-
all evaluation our respondents gave of their QoL (as
assessed by the VAS-DT), it appeared that this
‘‘clinical global impression’’ (20) was within the
proposed ‘‘gold standard limits.’’
Our findings are rather well in accordance with
those Cummins (69) found among 55 selected data
sets (population subgroups). Selection was based
on medical, psychiatric, of sociodemographic crite-
ria. Many of the mean QoL scores of these selected
subgroups lied around two standard deviations
above or below the ‘‘normative mean’’ (5proposed
‘‘gold standard’’ of QoL). As far as medical chronic
conditions were concerned, the mean scores of
these subgroups lied four standard deviations below
the ‘‘normative mean.’’ For physically disabled sub-
groups this figure was approximately two standard
deviations.
Underlying Quality of Life Dimensions
Almost all 13 QoL measures correlated signifi-
cantly with each other, which partly can be consid-
ered as a ‘‘validating procedure’’ (‘‘concurrent va-
lidity’’): 11 were not statistically significant (mostly
those with the ‘‘ASE), 53 correlation coefficients
were from .20–.50, and 14 were .50 or higher. Our
correlation matrix suggested the existence of at
least one more general overall QoL-dimension that
would be in agreement with Collings’ last study in
the United States (56). In this study, he constructed
an overall QoL-index from the QoL measures he
used. Therefore, we carried out an exploratory
‘‘second-order’’ PCA on these 13 measures. The
results are presented in Table 5.
All measures loaded high on the first factor sug-
gesting one underlying dimension: the OQOLI. This is
confirmed by the scree plot of the eigenvalues of the
extracted factors (Fig. 4).
There is a very clear elbow in the curve of consec-
utive eigenvalues, suggesting the existence of one
general underlying QoL-factor (70). A further rota-
tion according to the varimax criterium did not
reveal very clearly a simple structure of two factors
(Table 6), which again probably justifies the accep-
tance of one latent QoL-dimension, underlying our
QoL-measures.
However, some instruments loaded clearly
higher on the first and some others on the second
factor. Therefore, in order to look for two more
separated factors, we repeated the rotation proce-
Table 5. Second-order factor analysis
(principal components analysis):




















Figure 4. Second-order principal components analysis: scree
plot eigenvalues.
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dure but now replaced the orthogonal rotation by
an oblique one (Table 7).
As compared to the orthogonal procedure, now
much more clearly two factors could be distin-
guished: our QoL-measures loaded more clearly on
either the first or the second factor. Considering the
content of the measures that loaded highest on
either factor, the first factor seems to refer to ‘‘psy-
cho–physical health perceptions’’ (Cronbach’s alpha 5
.88) and the second to ‘‘psycho–social appraisal of
epilepsy’’ (Cronbach’s alpha 5 .82).
When we standardize the scores as before, scores
running again from 0–100, and divide the scores
into four equal categories (0–25, 26–50, 51–75, and
76–100), then it appears that none of our respon-
dents fell into the lowest category, while the sec-
ond, third, and fourth contained 9%, 63%, and 28%
of our respondents, respectively. The mean is 66.9
(sd 5 11.6, minimum score 5 32.4, maximum
score 5 90.1), which is below the hypothesized
‘‘gold standard’’ range of 75 6 2.5%, referred to
earlier (69).
Discussion and Conclusions
From a series of already existing QoL measures
covering the domains of QoL distinguished by
Spilker (20), we constructed a multidimensional
QoL profile of our group of persons with epilepsy.
From this profile it appeared that for many people
with epilepsy, their QoL was ‘‘fairly good.’’ Com-
pared to other chronically ill groups they often
showed similar or higher levels of QoL. However,
their situation differed markedly from the healthy
population with respect to educational level and
employment status, which in the so-called ‘‘social
indicators research’’ are considered as ‘‘objective
QoL indicators’’ (1). It is generally assumed that
these ‘‘objective indicators’’ are conducive to QoL
on the individual level. However, it should be no-
ticed that these kind of comparisons must be
treated cautiously because of differences between
samples concerning sampling procedures and sam-
ple bases. This may cause large differences with
respect to the composition of the various groups
under study, for example, with respect to duration
and onset of the disease, and demographic charac-
teristics such as age and sex. Moreover, one should
not only take the scale means into account but
possible differences in standard deviations between
groups as well.
In this context, one further remark should be
made as to the possible consequences of the sam-
pling procedures used in our study. As stated ear-
lier, our research group comprised a large number
of people with partial epilepsy. Besides technologic
(diagnostic) innovations we believe that this may be
mainly attributed to our sampling procedures: sam-
ple base and enrollment procedures. The sample
base consisted largely of patients from ‘‘third ech-
elon’’ outpatient clinics of a special epilepsy center,
while only patients who had an appointment with
their specialist were asked to participate in our
study. Both these aspects of our sampling proce-
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dures may have biased our sample in medical
and/or psychosocial respects (i.e., patients with
more medical and/or psychosocial problems may
have been enrolled into our study). A further indi-
cation of this may be found in the large percentage
of respondents who were a member of the Dutch
patient organization for people with epilepsy
(EVN), which is much higher than the one found in
the total population (30% versus 3%–4%). How-
ever, although we realize that our results may not
be generalized to the total epilepsy population, the
biased character of our sample may make our QoL
data even more promising. After all, it may be
expected that in less biased, more representative
samples, QoL will even be better (i.e., will be more
similar to that of the healthy population).
Twelve of the 13 QoL measures we used in our
study, appeared to constitute one single QoL-di-
mension underlying these measures. A further
analysis using PCA with oblique rotation yielded
two factors with one factor referring to ‘‘psycho–
physical health perceptions’’ and the second to ‘‘psy-
chosocial appraisal of epilepsy.’’ The advantage of such
higher-order factors is that they ‘‘…have often
proved useful in summarizing the results of large
analyses that produced many factors’’ (62). Conse-
quently, it allows for a more simple communication
of the information.
Some additional remarks should be made. First
of all, it should be noted that an oblique factor
solution may be somewhat more difficult to inter-
pret than an orthogonal rotation. But according to
Nunnally (61) there is no decisive reason to refrain
from oblique rotation. Both procedures ‘‘…lead to
essentially the same conclusions about the number
and kinds of factors’’ (62). Second, the two oblique
factors only explained a little bit more of the vari-
ance than the first factor found in the PC analysis
and less than the two factors after orthogonal rota-
tion. Third, the loadings on the first factor of the
PC-analysis as well as the scree plot of the consec-
utive eigenvalues of the PC-analysis suggested the
existence of one latent QoL dimension.§ For these
reasons one might be slightly in favour of one
factor. However, in addition, and in support of the
oblique two-factor solution, when primarily is
looked at the highest loadings on the two orthogo-
nal factors acquired after the orthogonal varimax-
rotation, we must add that the orthogonal two-
factor solution encountered, was very similar to the
oblique two-factor solution, therefore, supporting
the idea of two QoL-factors. This can be seen as a
valid reason to use the two separate factors instead
of only the first principal component.
As discussed earlier, in our study no QoL mea-
sures were developed de novo. Instead, already
existing, mostly generic QoL-measures were used.
The main reasons to propose such a procedure
were of theoretical, comparative, and resource-op-
timizing nature. After all, the QoL construct was
introduced to assess and evaluate more compre-
hensively the outcomes or effects of medical inter-
ventions. However, in view of theoretical modeling
(i.e., when one is primarily interested in the inter-
relations between the various aspects of QoL), the
QoL concept should be unfolded into its compo-
nents and hypothetically related to each other. This
is what has been proposed in models such as those
presented by Pope and Tarlov (30) and Verbrugge
and Jette (71). Our analyses seem to support the
feasibility and usefulness of such an approach.
A chronic illness may disturb someone’s life in
many respects, which is referred to before as ‘‘ill-
ness intrusiveness.’’ Because of a loss of resources it
places the affected people in a disadvantaged posi-
tion with respect to the achievement of valued goals
and interests (8,12,72). Therefore, a loss of resources
because of, for example, a chronic illness may stim-
ulate people to adapt, which implies: a shift of
means, standards, and goals giving the affected
people the opportunity to regain a sufficient satis-
factory level of well-being as defined by these peo-
ple themselves. This may also partly be interpreted
as a reduction of mental incongruence (73) between
the actual situation and the desired situation. These
processes will probably be more effective in the
psychosocial than in the physical domain of daily
functioning. From our discussion on a ‘‘noncat-
egorical approach’’ as well as from a recent publi-
cation of Kempen et al. (74), the picture emerges
that mental health was the least affected by a series
of chronic medical conditions while physical symp-
toms ‘‘…accounted for relatively high proportions
of the variance in HRQL.’’ Therefore, although their
QoL may have changed according to ‘‘objective
parameters’’ (e.g., employment, education, physical
functioning), after a process of adaptation people
may come to define their lives again as ‘‘satisfy-
ing.’’ That seemed to be the case for the majority of
our respondents, a conclusion that is in agreement
§ The factor correlation between our two factors is .494.
Nunnally and Bernstein (62) recommend that when in
exploratory analysis the correlation is $ .50, replacement
of the two factors with one should be considered. This
will reduce the dimensionality of the solution, often with
little reduction in fit. A correlation of $ .70 would be a
very strong reason to do so.
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with the findings and interpretations of Cassileth et
al. (26), Collings (33,54), and Cummins (69). Further
analysis of the patterns underlying these dynamic
processes deserves our further attention as is fur-
ther comparative and longitudinal research across
diseases, including epilepsy, and countries in
which QoL should be conceived as a ‘‘…socially
constructed phenomenon that must be addressed
by increasing opportunities for self-determination
in terms of both skill development and environ-
mental support’’ (75).
Further analyses relating socio–demographic
and clinical variables to QoL and exploring and
explaining the interrelations between the various
components of QoL will be subject of further pub-
lications and research.
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